Verano Holdings Corp Ordinary Shares - Class A (Sub Voting) VRNO

Morningstar Rating
CAD 4.46 −0.06 (1.33%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VRNO is trading at a 592% premium.
Price
CAD 6.31
Fair Value
CAD 65.99
Uncertainty
Extreme
1-Star Price
CAD 25.25
5-Star Price
CAD 7.74
Economic Moat
Qmd
Capital Allocation

News

Trading Information

Previous Close Price
CAD 4.52
Day Range
CAD 4.464.73
52-Week Range
CAD 4.099.27
Bid/Ask
CAD 4.44 / CAD 5.23
Market Cap
CAD 1.59 Bil
Volume/Avg
84,786 / 94,516

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.23
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

Verano Holdings Corp is a vertically integrated multi‐state cannabis operator in the United States. The Company has two reportable segments: (i) cultivation (wholesale) and (ii) retail. The company's consumer brands include Encore, Avexia, MÜV, Savvy, BITS and Verano. The company's retail dispensaries operate under brands including Zen Leaf and MÜV. The company derives its revenues from Retail segment.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
3,780

Comparables

Valuation

Metric
VRNO
AYR.A
CL
Price/Earnings (Normalized)
1.4952.31
Price/Book Value
0.920.341.21
Price/Sales
1.230.330.75
Price/Cash Flow
9.506.17
Price/Earnings
VRNO
AYR.A
CL

Financial Strength

Metric
VRNO
AYR.A
CL
Quick Ratio
0.480.571.22
Current Ratio
0.991.752.00
Interest Coverage
1.16−1.50−1.32
Quick Ratio
VRNO
AYR.A
CL

Profitability

Metric
VRNO
AYR.A
CL
Return on Assets (Normalized)
−2.09%−7.55%−3.73%
Return on Equity (Normalized)
−3.82%−18.32%−9.99%
Return on Invested Capital (Normalized)
0.10%−5.13%−0.55%
Return on Assets
VRNO
AYR.A
CL

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
DxxjltwfBhjfw$88.3 Bil
Merck KGaA ADR
MKKGY
JgmlmtbqygBqgqmg$78.0 Bil
Haleon PLC ADR
HLN
FxrydddnyTfrx$48.4 Bil
Viatris Inc
VTRS
JhgbdzfmWcg$13.8 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
RgrrsxyqZsf$13.5 Bil
Catalent Inc
CTLT
KtmgpwccFhmkms$10.9 Bil
Prestige Consumer Healthcare Inc
PBH
VsgrzlzCydgb$3.5 Bil
Perrigo Co PLC
PRGO
VmppyjxqJqj$3.5 Bil
Green Thumb Industries Inc
GTBIF
QsrqkpmnlXfzd$2.5 Bil
Curaleaf Holdings Inc
CURLF
PprhtljlQfyl$2.3 Bil

Sponsor Center